Blog
Building on the PhRMA Foundation’s Little-Known History
The PhRMA Foundation has quietly been doing its work for 57 years. When I joined as its President late last ...
Read More
Read More
Towards Better Data Dashboards for Cost-Effectiveness Analyses
Assessing the value of a specific drug or medical intervention is a complicated, multilayered process. Conventional cost-effectiveness ratios (i.e., in ...
Read More
Read More
What Low-Value Care Means for Health Equity
The coronavirus pandemic has laid bare the significant health disparities present within the American health care system. Not only has ...
Read More
Read More
The Patient Perspective Approach Should Guide Value Assessments of COVID-19 Vaccines
As the United States continues its mass rollout of the COVID-19 vaccine, key questions remain concerning how policymakers should value ...
Read More
Read More
Centering the Patient Perspective in Hepatitis C Treatment Evaluation
In recent years, a growing chorus of patients, providers, and health economics researchers have been calling for a new approach ...
Read More
Read More
How MCDA Can Drive Better Value Assessment
Traditional measures of value used in cost-effectiveness analyses are not, by definition, fully comprehensive or sufficiently flexible to allow for ...
Read More
Read More
The Voices in Value Year in Review 2020
Although 2020 ushered in unprecedented challenges that tested the American health care system, it also presented a unique opportunity to ...
Read More
Read More
Racial and Ethnic Disparities in Health Care are Found in the Missing Patient Voice
COVID-19 has exposed dramatic vulnerabilities in our society and it is becoming clearer that minority communities are hit harder than ...
Read More
Read More
Valuing Diversity in Value Assessment
The historic events of 2020 – from the COVID-19 pandemic to a nation-wide reckoning with systemic racism – has brought ...
Read More
Read More
